| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | AUSTRALIAN CLINICAL LABS LIMITED: Change in substantial holding | - | ASX | ||
| Mo | AUSTRALIAN CLINICAL LABS LIMITED: Change of Director's Interest Notice - S Butler | - | ASX | ||
| AUSTRALIAN CLINICAL LABS Aktie jetzt für 0€ handeln | |||||
| 31.08. | AUSTRALIAN CLINICAL LABS LIMITED: Initial Director's Interest Notice - G Horan | - | ASX | ||
| 31.08. | AUSTRALIAN CLINICAL LABS LIMITED: Final Director's Interest Notice - M McGrath | - | ASX | ||
| 31.08. | AUSTRALIAN CLINICAL LABS LIMITED: Notification regarding unquoted securities - ACL | 1 | ASX | ||
| 31.08. | AUSTRALIAN CLINICAL LABS LIMITED: Notification regarding unquoted securities - ACL | 1 | ASX | ||
| 31.08. | AUSTRALIAN CLINICAL LABS LIMITED: Notification of cessation of securities - ACL | 1 | ASX | ||
| 24.08. | AUSTRALIAN CLINICAL LABS LIMITED: Ceasing to be a substantial holder | 1 | ASX | ||
| 21.08. | AUSTRALIAN CLINICAL LABS LIMITED: Change in substantial holding from MUFG | 1 | ASX | ||
| 20.08. | AUSTRALIAN CLINICAL LABS LIMITED: Change in substantial holding | - | ASX | ||
| 19.08. | AUSTRALIAN CLINICAL LABS LIMITED: Ceasing to be a substantial holder | - | ASX | ||
| 17.08. | Australian Clinical Labs Ltd Reveals Fall In Full Year Profit | 1 | RTTNews | ||
| 17.08. | Australian Clinical Labs FY26 slides: margins expand despite revenue headwinds | 2 | Investing.com | ||
| 17.08. | Australian Clinical Labs delivers profit growth and stronger margins in FY26 | 2 | The Motley Fool Australia | ||
| 17.08. | AUSTRALIAN CLINICAL LABS LIMITED: Dividend/Distribution - ACL | 1 | ASX | ||
| 17.08. | AUSTRALIAN CLINICAL LABS LIMITED: FY26 financial results investor presentation | 1 | ASX | ||
| 17.08. | AUSTRALIAN CLINICAL LABS LIMITED: Appendix 4E and FY26 financial reports | 1 | ASX | ||
| 10.08. | AUSTRALIAN CLINICAL LABS LIMITED: FY26 Results Investor Webinar | - | ASX | ||
| 10.08. | AUSTRALIAN CLINICAL LABS LIMITED: Date of 2026 AGM | 1 | ASX | ||
| 31.07. | AUSTRALIAN CLINICAL LABS LIMITED: Becoming a substantial holder | - | ASX |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| CARL ZEISS MEDITEC | 29,460 | +1,52 % | SFC Energy, Dürr, Carl Zeiss Meditec, SFC Energy schauen nach Dehli zum BRIC's Gipfel - und Trump golft | Zeitenwende. Die Musik spielt in Dehli. Carl Zeiss MediTec, SFC Energy, Dürr, Wacker Chemie - you name it. Deutsche Small- und MidCaps müssen die Chance der Veränderung nutzen. Vielelicht noch mehr... ► Artikel lesen | |
| ECKERT & ZIEGLER | 12,120 | -0,90 % | Eckert&Ziegler-Aktie im Check am 19.09. (10:40 Uhr): Meine aktuelle Lageeinschätzung | ||
| MEDTRONIC | 80,48 | +0,32 % | Medtronic plc: Medtronic announces FDA clearance for LigaSure RAS Maryland instrument on the Hugo RAS system | Trusted vessel-sealing technology used in more than 45 million procedures worldwide is now cleared for robotic-assisted surgery in the U.S. GALWAY, Ireland, Sept. 16, 2026 /PRNewswire/... ► Artikel lesen | |
| STRATEC | 24,250 | +0,83 % | Stratec: Kurs kommt in Schwung | Zu Corona-Zeiten kannte der Aktienkurs von Stratec nur den Weg steil nach oben. So stark gefragt waren die in Medizinlaboren eingesetzten Analysegeräte von Stratec. Doch wie bei vielen anderen Aktien... ► Artikel lesen | |
| M1 AESTHETICS | 12,900 | -0,77 % | Dividendenbekanntmachungen (08.07.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) A2 MILK COMPANY LIMITED NZATME0002S8 0,4135 NZD 0,2059 EUR AGRANA BETEILIGUNGS-AG AT000AGRANA3 - 0,35 EUR BANK OF CHONGQING CO LTD CNE100001QN2 0... ► Artikel lesen | |
| M1 KLINIKEN | 19,880 | -3,50 % | M1 Kliniken steigert Beauty-Gewinn deutlich | M1 Kliniken hat im Kerngeschäft Beauty im ersten Halbjahr 2026 den Umsatz um 11 Prozent von 51,2 Millionen auf 56,9 Millionen Euro gesteigert. Das Segment-EBIT wuchs deutlich stärker um 23,8 Prozent... ► Artikel lesen | |
| ZIMMER BIOMET | 82,74 | -0,34 % | Is Zimmer Biomet Stock Underperforming the Nasdaq? | ||
| RYMAN HEALTHCARE | 0,893 | 0,00 % | XFRA RH7: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| SONIC HEALTHCARE | 12,002 | +0,49 % | Dividendenbekanntmachungen (02.09.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AEGON LTD BMG0112X1056 - 0,21 EUR AMKOR TECHNOLOGY INC US0316521006 0,0835 USD 0,072 EUR AVERY DENNISON CORP US0536111091 1 USD 0... ► Artikel lesen | |
| AMBU | 8,770 | -0,28 % | Ambu A/S: Interim Report For Q3 | 25.8.2026 18:01:05 CEST | Ambu A/S |
Interim report (Q1 and Q3)
In Q3 2025/26, Ambu delivered organic revenue growth of 10.3%, driven by strong performance in Endoscopy Solutions growing 16.0% organically.... ► Artikel lesen | |
| TRANSMEDICS GROUP | 74,88 | -0,48 % | TransMedics Appoints Fernando Araujo CFO And Reiterates $737 Million To $757 Million 2026 Revenue Outlook | ||
| CLINICA BAVIERA | 56,40 | -1,05 % | Dividendenbekanntmachungen (10.06.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ALIBABA GROUP HOLDING LTD KYG017191142 0,1312 USD 0,1137 EUR ALIBABA GROUP HOLDING LTD SDR SGXE32143393 0,0259 SGD 0,0175 EUR ALTAREA... ► Artikel lesen | |
| CVS | 15,200 | +1,33 % | Converium Capital Inc.: Converium Capital Sends Letter to CVS Group Board Highlighting Company's Undervaluation and Urging £100 Million Share Buyback | Follows Extensive Private Engagement That Has Not Produced Meaningful Action
Converium Capital Inc. ("Converium"), which manages funds that own shares of CVS Group plc (LSE: CVSG) ("CVS Group"... ► Artikel lesen | |
| EMBLA MEDICAL | 3,545 | +0,14 % | EMBLA MEDICAL HF: Transactions in relation to Share Buyback Program | ||
| EUROEYES | - | - | EUROEYES (01846): INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2026 |